ulation that will be elicited by a given artificial activator due to many additional factors that impact AD function.
The ability of natural ADs to interact with multiple profunctional contexts in order to increase transcriptional tein targets may account for this functional flexibility. potency and facilitate subsequent experiments testing Although changing the DBD and hence presentation of the AD might affect interactions with a subset of transcription protein targets, it is unlikely to affect all. However, given that our ligands were identified based upon their ability to bind to a single transcription protein, we initially chose a DBD that most closely mimicked the presentation of the ligands in the binding screen. Thus, because the peptides were attached to solid support with the amino terminus free, the selected ligands were fused to the LexA DBD at the amino terminus of the protein (Figure 2 ). To test if the Med15 ligands require a particular presentation to function as ADs, we first investigated the function of 28 fused to a commonly used DBD derived from the S. cerevisiae protein Gal4, Gal4(1-147). The first 50 residues of Gal4 form a Cys 6 -Zn cluster that binds to DNA and the subsequent 50 mediate dimerization through helix-helix interactions that enhance sequence-specific DNA binding [37, 38] . The remaining 47 amino acid residues serve as a linker region of unde- quantitative β-galactosidase assays. As illustrated in Figure 3B , the relationship between potency and bindThus, the additional linker residues present in the Gal4 (1-147) activator containing two copies of a well-studied AD ference between the artificial ADs isolated from our binding screen and most natural ADs. derived from VP16 upregulated transcription 5-fold more effectively than an activator containing a single copy of the AD [48] . From the standpoint of artificial Specificity of Function Natural activation domains typically interact with a activator design, the latter approach is particularly attractive because it requires a change only in the number of transcriptional machinery proteins. The well characterized yeast transcriptional activator Gal4, for structure of the artificial transcriptional activator rather than alteration of the regulatory DNA sequences assoexample, has more than 10 identified target proteins, although the physiological relevance of all the interacciated with the targeted gene in order to produce greater levels of transcription.
tions has yet to be established [ with Med15, it has several additional putative targets in the transcriptional machinery, and thus its function is Among all of the constructs, only the trimer of 32 (Figure 4B) Gal4(1-147)+28x2, Gal4(1-147)+32x2, Gal4(1-147)+28+32 , by a quantitative liquid β-galactosidase assay in accordance with established methods [39] . Briefly, the plasmids encoding the and Gal4(1-147)+32+28 To construct plasmids encoding the Gal4(1-147)+28x2, Gal4 ligand+DBD fusions and the DBD plasmid (negative control) were transformed into yeast using the LiOAc method or by electropora- (1-147)+32x2, Gal4(1-147)+28+32, and Gal4(1-147) +32+28 fusions, two pairs of oligonucleotides coding for each of the peptides and tion, and transformed colonies were selected by growth on synthetic complete (SC) media containing 2% raffinose and lacking the linkers were designed and separately annealed. The annealed oligonucleotides for either peptide 28 or peptide 32 (5#-AATTT GGT appropriate amino acid(s) for selection. Freshly transformed colonies were used to inoculate 5 ml cultures of SC media containing TCT GGT GGT TCT GGT NNN NNN NNN NNN NNN NNN NNN NNN  GGT ACC G-3# and 5#-GATCC GGTACC NNN NNN NNN NNN 
